Articles published in Journal of Vaccines & Vaccination have been cited by esteemed scholars and scientists all around the world. Journal of Vaccines & Vaccination has got h-index 24, which means every article in Journal of Vaccines & Vaccination has got 24 average citations.

Following are the list of articles that have cited the articles published in Journal of Vaccines & Vaccination.

Journal total citations count 2341
Journal impact factor 2.87
Journal 5 years impact factor 3.73
Journal cite score 4.69
Journal h-index 24
Important citations

PREVALENCE OF HEPATITIS B VIRUS INFECTION IN HEALTH CARE WORKERS OF A TERTIARY CARE HOSPITAL

Novel Aspects and Strategies in Vaccination

Hexavalent vaccines: What can we learn from head-to-head studies?

Immunogenicity and safety of a fully liquid DTaP-IPV-HB-PRP?T hexavalent vaccine compared with the standard of care in infants in the Republic of Korea.

DTaP-IPV-HepB-Hib Vaccine (Hexyon®): An Updated Review of its Use in Primary and Booster Vaccination.

DTaP-IPV-Hep B-Hib vaccine (Hexyon ® /Hexacima ® ): a guide to its use in the primary and booster vaccination of infants and toddlers in Europe

Combined immunogenicity data for a new DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim) following primary series administration at 2, 4, 6 months of age in Latin America.

Hexavalent vaccines in infants: a systematic literature review and meta-analysis of the solicited local and systemic adverse reactions of two hexavalent vaccines.

Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP?T vaccination at 2, 4 and 6 months.

Hexavalent vaccines for immunization in paediatric age

Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants.

New perspectives for hexavalent vaccines.

Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration.

DTaP-IPV-Hep B-Hib vaccine (Hexaxim®) : a review of its use in primary and booster vaccination.

Novel Aspects and Strategies in Vaccination

Development of Prophylactic Bivalent and Quadrivalent Human Papillomavirus (HPV) Vaccines: A Review

Immunogenicity of Antigen Adjuvanted with AS04 and Its Deposition in the Upper Respiratory Tract after Intranasal Administration

Novel Aspects and Strategies in Vaccination

Cytochrome B - Analysis of Hydrophobicity, Surface Accessibility,Antigenicity and Prediction of MHC I and MHC II Binders fromDracunculiasis

Novel Aspects and Strategies in Vaccination